ALLIANCE A171601

Primary Category:

Treatment Protocols

Disease Category:

Breast, Breast Metastatic

Status:

Closed

A Phase II Trial Assessing the Tolerability of Palbociclib in Combination with Letrozole or Fulvestrant in Patients Aged 70 and Older with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer

NCT#03633331

Eligible for screening study DCP 001

Effective Tuesday, March 3rd, 2020, at 4:30 PM ET, study A171601 will be permanently closed to new patient registration.